Epitomee Medical Ltd (EPIT) — Capital Reinvestment Ratio
Latest as of December 2020:
0.01x
Epitomee Medical Ltd (EPIT) has a Capital Reinvestment Ratio of 0.01x as of December 2020, meaning it reinvests 0% of its operating cash flow (ILA27.75 Million) in capital expenditures (ILA179.29K). See how much free cash does Epitomee Medical Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
ILA27.75 Million
ILA
Capital Expenditures
ILA179.29K
ILA
Data as of
Dec 2020
Most recent filing
Epitomee Medical Ltd Capital Reinvestment Ratio (2020–2020)
This chart tracks Epitomee Medical Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Epitomee Medical Ltd (2020–2020)
Year-by-year Capital Reinvestment Ratio for Epitomee Medical Ltd from 2020 to 2020. For live market cap and broader valuation context, see Epitomee Medical Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.02x | ILA6.75 Million | ILA104.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow